Akoya Biosciences (AKYA) Short Interest Ratio & Short Volume $1.29 0.00 (0.00%) As of 07/8/2025 Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Akoya Biosciences Short Interest DataAkoya Biosciences (AKYA) has a short interest of 2.64 million shares, representing 12.67% of the float (the number of shares available for trading by the public). This marks a -7.04% decrease in short interest from the previous month. The short interest ratio (days to cover) is 5.7, indicating that it would take 5.7 days of the average trading volume of 416,191 shares to cover all short positions.Current Short Interest2,640,000 sharesPrevious Short Interest2,840,000 sharesChange Vs. Previous Month-7.04%Dollar Volume Sold Short$3.25 millionShort Interest Ratio5.7 Days to CoverLast Record DateJune 15, 2025Outstanding Shares49,954,000 sharesFloat Size20,840,000 sharesShort Percent of Float12.67%Today's Trading Volume0 sharesAverage Trading Volume416,191 sharesToday's Volume Vs. Average0% Short Selling Akoya Biosciences? Sign up to receive the latest short interest report for Akoya Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAKYA Short Interest Over TimeAKYA Days to Cover Over TimeAKYA Percentage of Float Shorted Over Time Akoya Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/20252,640,000 shares $3.25 million -7.0%12.7%5.7 $1.23 5/31/20252,840,000 shares $3.51 million +18.3%13.7%5.9 $1.24 5/15/20252,400,000 shares $2.40 million +12.2%11.5%4.9 $1.00 4/30/20252,140,000 shares $2.57 million +3.4%10.3%8.7 $1.20 4/15/20252,070,000 shares $2.46 million -10.8%10.0%7.5 $1.19 3/31/20252,320,000 shares $3.22 million -6.8%11.2%3.6 $1.39 3/15/20252,490,000 shares $3.74 million -30.8%12.0%3.9 $1.50 2/28/20253,600,000 shares $5.87 million +10.8%17.4%5.1 $1.63 2/15/20253,250,000 shares $7.51 million +60.1%15.8%4.9 $2.31 1/31/20252,030,000 shares $5.93 million -6.5%9.9%3.1 $2.92 Get the Latest News and Ratings for AKYA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Akoya Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/15/20252,170,000 shares $5.97 million +24.0%4.4%3.6 $2.75 12/31/20241,750,000 shares $4.01 million -3.3%8.5%3.3 $2.29 12/15/20241,810,000 shares $4.11 million +20.7%9.1%7.9 $2.27 11/30/20241,500,000 shares $3.30 million +18.1%7.5%6.6 $2.20 11/15/20241,270,000 shares $3.06 million -20.6%6.4%8.2 $2.41 10/31/20241,600,000 shares $4.51 million -20.8%7.8%12.1 $2.82 10/15/20242,020,000 shares $6.32 million -14.4%9.1%13.2 $3.13 9/30/20242,360,000 shares $6.42 million -23.6%10.7%14.3 $2.72 9/15/20243,090,000 shares $9.08 million -6.4%14.0%16.9 $2.94 8/31/20243,300,000 shares $8.42 million -1.8%15.0%16 $2.55 8/15/20243,360,000 shares $7.36 million +6.3%15.2%12.4 $2.19 7/31/20243,160,000 shares $7.81 million +6.4%14.3%8.7 $2.47 7/15/20242,970,000 shares $6.92 million +14.2%13.4%8.7 $2.33 6/30/20242,600,000 shares $6.08 million +15.6%11.9%7.7 $2.34 6/15/20242,250,000 shares $4.97 million +10.3%10.3%6.9 $2.21 5/31/20242,040,000 shares $4.39 million +75.9%9.3%6.7 $2.15 5/15/20241,160,000 shares $3.24 million +11.5%5.3%4.2 $2.79 4/30/20241,040,000 shares $3.97 million +3.0%4.9%6.3 $3.82 4/15/20241,010,000 shares $4.05 million +2.2%4.7%5.6 $4.01 3/31/2024988,400 shares $4.64 million -5.9%4.7%4.8 $4.69 3/15/20241,050,000 shares $5.16 million +25.7%4.9%5.2 $4.91 2/29/2024835,500 shares $4.80 million +8.1%3.9%4 $5.74 2/15/2024773,200 shares $4.50 million +5.3%3.6%4 $5.82 1/31/2024734,600 shares $3.73 million +2.5%3.3%4 $5.08 1/15/2024716,800 shares $3.71 million +13.6%3.2%4.3 $5.18 12/31/2023631,000 shares $3.08 million -17.6%2.8%4.1 $4.88 12/15/2023765,300 shares $3.40 million -13.8%3.4%5.3 $4.44 11/30/2023887,600 shares $3.90 million -10.0%4.0%5.8 $4.39 11/15/2023986,100 shares $4.39 million -18.5%4.4%6.6 $4.45 10/31/20231,210,000 shares $4.24 million +16.4%5.4%7.6 $3.50It’s my duty to share the “truth” I see behind this bible verse (Ad)Former CIA advisor Jim Rickards believes President Trump has just unlocked what the Bible foretold — a $150 trillion “birthright” tied to America’s untouched wealth. He says the Book of Genesis predicted this moment… and those who act now could be first in line to benefit. The full presentation is now live.See Jim Rickards' take on America’s $150 trillion birthright 10/15/20231,040,000 shares $3.72 million +9.6%4.7%6.5 $3.58 9/30/2023949,100 shares $4.41 million +24.2%4.3%6.1 $4.65 9/15/2023764,200 shares $3.32 million +14.4%3.4%4.9 $4.34 8/31/2023668,100 shares $3.47 million +1.8%3.1%3 $5.20 8/15/2023656,200 shares $3.63 million -4.1%3.1%2.6 $5.53 7/31/2023684,500 shares $4.72 million -5.8%3.2%2.8 $6.90 7/15/2023726,700 shares $5.07 million +5.5%3.4%3 $6.98 6/30/2023688,900 shares $5.09 million 0.0%3.3%2.9 $7.39 6/15/2023689,200 shares $5.75 million -0.4%3.3%3 $8.35 5/31/2023691,800 shares $3.89 million +1.7%4.1%4.1 $5.63 5/15/2023680,000 shares $3.94 million +1.0%4.0%5.9 $5.80 4/30/2023673,300 shares $4.69 million +2.6%4.0%6 $6.96 4/15/2023656,500 shares $4.62 million +56.0%3.9%5.8 $7.04 3/31/2023420,900 shares $3.44 million -41.8%2.5%3.5 $8.18 3/15/2023722,700 shares $6.15 million +45.1%4.3%5.5 $8.51 2/28/2023498,000 shares $5.74 million +3.0%2.9%4.4 $11.53 2/15/2023483,400 shares $6.01 million -4.1%2.8%3.8 $12.43 1/31/2023503,800 shares $5.67 million -11.9%3.0%3.9 $11.25 1/15/2023571,500 shares $6.16 million -5.2%3.4%4.5 $10.78 12/30/2022602,700 shares $5.77 million +22.2%3.5%4.9 $9.57 12/15/2022493,400 shares $6.05 million -68.0%2.9%4.1 $12.26 11/30/20221,540,000 shares $19.99 million -7.2%9.0%10.4 $12.98 11/15/20221,660,000 shares $21.63 million -8.3%9.7%12 $13.03 10/31/20221,810,000 shares $24.89 million -4.2%10.6%12.6 $13.75 10/15/20221,890,000 shares $22.08 million -2.1%11.1%13.1 $11.68 9/30/20221,930,000 shares $22.68 million +1.1%11.3%11.8 $11.75 9/15/20221,910,000 shares $24.56 million +147.4%11.2%10.9 $12.86 8/31/2022772,200 shares $8.80 million +11.1%4.6%4.7 $11.40 8/15/2022694,900 shares $10.76 million -2.3%4.1%5.2 $15.49 7/31/2022711,300 shares $10.02 million -12.9%4.2%5.4 $14.08 7/15/2022816,400 shares $10.90 million +3.0%4.9%6.6 $13.35 6/30/2022792,700 shares $10.19 million +25.1%4.7%7.6 $12.85 6/15/2022633,700 shares $6.60 million -3.0%3.8%7.9 $10.42 5/31/2022653,000 shares $7.61 million -4.8%3.9%10 $11.65 5/15/2022686,200 shares $6.81 million -0.6%4.1%11.7 $9.93 4/30/2022690,300 shares $6.50 million +19.4%4.2%12.6 $9.41 4/15/2022578,100 shares $6.50 million +15.1%3.5%10.8 $11.24 3/31/2022502,400 shares $5.52 million -2.5%3.1%8.1 $10.99 3/15/2022515,400 shares $5.77 million +2.5%3.2%5.2 $11.19 2/28/2022503,000 shares $5.57 million +15.7%3.1%3.5 $11.08 2/15/2022434,600 shares $5.21 million +0.7%2.7%2.7 $11.98 1/31/2022431,800 shares $4.91 million +2.8%2.7%2.2 $11.36 1/15/2022420,200 shares $5.21 million -21.5%2.6%2 $12.41 12/31/2021535,100 shares $8.19 million -7.4%3.3%2.6 $15.31 12/15/2021578,100 shares $7.54 million +78.4%3.6%3 $13.04 11/30/2021324,100 shares $4.21 million -19.5%2.0%2.1 $12.98 11/15/2021402,700 shares $5.26 million -21.9%2.5%3.1 $13.07 10/29/2021515,900 shares $6.84 million -21.4%3.2%5 $13.25 10/15/2021656,400 shares $8.34 million +10.9%4.1%6.2 $12.70 9/30/2021592,000 shares $8.26 million +36.9%3.7%5.2 $13.96It’s my duty to share the “truth” I see behind this bible verse (Ad)Former CIA advisor Jim Rickards believes President Trump has just unlocked what the Bible foretold — a $150 trillion “birthright” tied to America’s untouched wealth. He says the Book of Genesis predicted this moment… and those who act now could be first in line to benefit. The full presentation is now live.See Jim Rickards' take on America’s $150 trillion birthright 9/15/2021432,500 shares $7.18 million +12.0%2.7%3.3 $16.60 8/31/2021386,300 shares $6.17 million +8.2%2.4%2.9 $15.97 8/13/2021357,200 shares $5.53 million No Change2.2%2.6 $15.48 AKYA Short Interest - Frequently Asked Questions What is Akoya Biosciences' current short interest? Short interest is the volume of Akoya Biosciences shares that have been sold short but have not yet been covered or closed out. As of June 15th, traders have sold 2,640,000 shares of AKYA short. 12.67% of Akoya Biosciences' shares are currently sold short. Learn More on Akoya Biosciences' current short interest. What is a good short interest ratio for Akoya Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AKYA shares currently have a short interest ratio of 6.0. Learn More on Akoya Biosciences's short interest ratio. What is a good short interest percentage for Akoya Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.67% of Akoya Biosciences' floating shares are currently sold short. Is Akoya Biosciences' short interest increasing or decreasing? Akoya Biosciences saw a decrease in short interest in the month of June. As of June 15th, there was short interest totaling 2,640,000 shares, a decrease of 7.0% from the previous total of 2,840,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Akoya Biosciences' float size? Akoya Biosciences currently has issued a total of 49,954,000 shares. Some of Akoya Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Akoya Biosciences currently has a public float of 20,840,000 shares. How does Akoya Biosciences' short interest compare to its competitors? 12.67% of Akoya Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "measuring and control equipment" compare to Akoya Biosciences: 908 Devices Inc. (9.52%), Frequency Electronics, Inc. (3.22%), Kewaunee Scientific Corporation (2.87%), Rapid Micro Biosystems, Inc. (2.60%), Owlet, Inc. (9.13%), Seer, Inc. (5.41%), Optex Systems Holdings Inc. (0.55%), Prenetics Global Limited (0.71%), Nautilus Biotechnology, Inc. (0.51%), inTEST Co. (0.67%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short Akoya Biosciences stock? Short selling AKYA is an investing strategy that aims to generate trading profit from Akoya Biosciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Akoya Biosciences? A short squeeze for Akoya Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AKYA, which in turn drives the price of the stock up even further. How often is Akoya Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AKYA, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies 908 Devices Short Squeeze Frequency Electronics Short Squeeze Kewaunee Scientific Short Squeeze Rapid Micro Biosystems Short Squeeze Owlet Short Squeeze Seer Short Squeeze Optex Systems Short Squeeze Prenetics Global Short Squeeze Nautilus Biotechnology Short Squeeze inTEST Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AKYA) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredURGENT: Trump Could Buy 1,000,000 Bitcoins TOMORROW?According to one report, senior officials and crypto insiders recently discussed Bitcoin accumulation at the h...Paradigm Press | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akoya Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Akoya Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
